Latest Industry Insights

With justice and health in the balance, modern forensic toxicology drug testing labs are expected to detect and quantify a wide range of drugs and metabolites, from Fentanyl to novel psychoactive substances (NPS), at very low levels in biological matrices. The drug concentrations also need to be correlated with the impairment of the individual with absolute certainty, but labs face increasing pressures due to growing caseloads, sample backlogs, and budget restrictions.

Laboratories rely on the constant provision of high quality water for a variety of purposes, from glass washing to reagent preparation and instrumental analysis. It is all too easy to take this valuable commodity for granted yet, behind the scenes, a great deal of thought goes into designing a facility that reliably and cost-effectively provides water of the required quality on a round the clock basis.

We spoke to Francesco Trevisani and Giovanni Rizzo to learn more about Biorek and how the ZCube accelerator programme is helping to drive the project forward.

Despite the important role glass plays in science, the skill to develop the glassware is in decline. Scientific glassblowing has now been classed as an endangered craft by The Radcliffe Trust.

We recently caught up with BBI’s Managing Director, Liam Taylor, to discuss the expansion of lateral flow testing as a tool for diagnostics and patient monitoring.

We spoke to Dr Philipp Pagel, CMO at numares AG, to learn about some of the limitations of current in vitro diagnostics, and how software based technologies can help overcome some of these.

We spoke to Dirk Löffert, Ph.D., CEO of Biomillenia, to learn about some of the challenges of isolating live bacterial species, and how microbiome-on-a-chip technology can help overcome some of these.

To learn about the importance of the extracellular matrix and some of the limitations of current organoid culture systems, we spoke to Colin Sanctuary, CEO and founder of QGel, a spin-out from EPFL.

We spoke to Dr Sacha Loiseau, developer of Cellvizio®, to learn more about optical biopsy and the benefits it can bring to the clinic.

CDI’s content of 81% of the human proteome (>23,000 proteins) is the largest human protein array in the world.